Thorac Cardiovasc Surg 2017; 65(S 03): S191-S195
DOI: 10.1055/s-0037-1601342
Tribute
Georg Thieme Verlag KG Stuttgart · New York

Transcatheter Aortic Valve Implantation: A Deal with the Devil?

Thomas Walther
1  Kerckhoff Herzzentrum, Klinik für Herzchirurgie, Bad Nauheim, Germany
,
Jörg Kempfert
2  Deutsches Herzzentrum Berlin, Klinik für Herzchirurgie, Berlin, Germany
,
Axel Linke
3  Herzzentrum Leipzig, Klinik für Kardiologie, Leipzig, Germany
› Author Affiliations
Further Information

Publication History

01 March 2017

01 March 2017

Publication Date:
07 April 2017 (online)

Introduction

At the beginning of this millennium, the number of elderly and high-risk patients steadily increased in cardiac surgical practice. Initial developments of alternative minimally invasive transcatheter techniques were made by technicians from different companies together with physicians Alain Carpentier (Rouen, France) and Eberhard Grube (Siegburg, Germany). In early 2004 Friedrich Mohr, who served together with Michael Mack as an advisor to a valve company, thought about the potential for simple and safe implantation of such transcatheter valves. His personal contacts together with his vision to further explore the field of transcatheter techniques enabled us to evaluate initial devices in an experimental setting in Irvine, California, United States in autumn 2004. For these early experiential experiences, a multiinstitutional team from Dallas, Frankfurt, and Leipzig was built.